World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
96
Citations
34970
World Ranking
9632
National Ranking
533

Overview

Frank Lammert is affiliated with Saarland University in Germany and has contributed extensively to the field of medicine, with a focus on epidemiology, hepatology, surgery, oncology, and pulmonary and respiratory medicine. Their work encompasses a broad array of subjects related to liver diseases, including diagnosis, treatment, transplantation, and immunological aspects.

Their academic contributions include publications in key areas such as liver disease diagnosis and treatment, liver disease and transplantation, pediatric hepatobiliary diseases and treatments, liver diseases and immunity, COVID-19 clinical research studies, diet, metabolism, and disease, and gallbladder and bile duct disorders.

Recent notable papers by Lammert include:

  • Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases, 2021, Hepatology
  • Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population, 2021, Clinical Gastroenterology and Hepatology
  • European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations, 2020, United European Gastroenterology Journal
  • The Treatment of Gallstone Disease, 2020, Deutsches Ärzteblatt international
  • Budesonide Orodispersible Tablets Maintain Remission in a Randomized, Placebo-Controlled Trial of Patients With Eosinophilic Esophagitis, 2020, Gastroenterology

Throughout their career, Lammert has frequently collaborated with researchers including Marcin Krawczyk, Matthias Reichert, Susanne N. Weber, Markus Casper, and Thomas Berg.

Their research has been disseminated widely through publication venues such as Zeitschrift für Gastroenterologie, Journal of Hepatology, Liver International, Gastroenterology, and bioRxiv (Cold Spring Harbor Laboratory).

Best Publications

  • EASL Clinical Practice Guidelines: management of cholestatic liver diseases

    Ulrich Beuers;Kirsten M. Boberg;Roger W. Chapman;Olivier Chazouillères

  • Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.

    Adriaan J. van der Meer;Bart J. Veldt;Jordan J. Feld;Heiner Wedemeyer

  • The Collaborative Cross, a community resource for the genetic analysis of complex traits

    Gary A. Churchill;David C. Airey;Hooman Allayee;Joe M. Angel

  • Bacterial infections in cirrhosis: A position statement based on the EASL Special Conference 2013

    Rajiv Jalan;Javier Fernandez;Reiner Wiest;Bernd Schnabl

  • A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis

    Stephan Buch;Felix Stickel;Eric Trépo;Michael Way

  • The nature and identification of quantitative trait loci: a community's view.

    Oduola Abiola;Joe M. Angel;Philip Avner;Alexander A. Bachmanov

  • Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice

    Peter Fickert;Andrea Fuchsbichler;Martin Wagner;Gernot Zollner

  • EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones

    F. Lammert;M. Acalovschi;G. Ercolani;K.J. van Erpecum

  • A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease

    Stephan Buch;Clemens Schafmayer;Henry Völzke;Christian Becker

  • First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

    Harpreet S Wasan;Peter Gibbs;Navesh K Sharma;Julien Taieb

  • Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis.

    Thomas Reiberger;Arnulf Ferlitsch;Berit A. Payer;Mattias Mandorfer

  • Intrahepatic cholestasis of pregnancy: A randomized controlled trial comparing dexamethasone and ursodeoxycholic acid

    Anna Glantz;Hanns-Ulrich Marschall;Frank Lammert;Lars-Åke Mattsson

  • Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans

    Sonja Hillebrandt;Sonja Hillebrandt;Hermann E Wasmuth;Ralf Weiskirchen;Claus Hellerbrand

  • Genetic and environmental influences on symptomatic gallstone disease : a swedish study of 43,141 Twin Pairs

    Despina Katsika;Andrej Grjibovski;Curt Einarsson;Frank Lammert

  • Effects of Ursodeoxycholic and Cholic Acid Feeding on Hepatocellular Transporter Expression in Mouse Liver

    Peter Fickert;Gernot Zollner;Andrea Fuchsbichler;Conny Stumptner

  • Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles.

    Peter Fickert;Gernot Zollner;Andrea Fuchsbichler;Conny Stumptner

  • Functional Variants of the Central Bile Acid Sensor FXR Identified in Intrahepatic Cholestasis of Pregnancy

    Saskia W.C. van Mil;Alexandra Milona;Peter H. Dixon;Roman Mullenbach

  • Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma

    Ander Arbelaiz;Mikel Azkargorta;Marcin Krawczyk;Alvaro Santos-Laso

  • Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells

    Jonel Trebicka;Martin Hennenberg;Margarete Odenthal;Khanwali Shir

  • 1183 GENETIC VARIATION IN THE PNPLA3 GENE IS ASSOCIATED WITH ALCOHOLIC LIVER INJURY IN CAUCASIANS

    F. Stickel;S. Buch;K. Lau;H. Meyer zu Schwabedissen

Frequent Co-Authors

Tilman Sauerbruch
Tilman Sauerbruch University of Bonn
Stefan Zeuzem
Stefan Zeuzem Goethe University Frankfurt
Christian Trautwein
Christian Trautwein RWTH Aachen University
Ulrich Spengler
Ulrich Spengler University of Bonn
Jochen Hampe
Jochen Hampe TU Dresden
Piero Portincasa
Piero Portincasa University of Bari Aldo Moro
Michael P. Manns
Michael P. Manns Hannover Medical School
Sabina Janciauskiene
Sabina Janciauskiene Hannover Medical School
Michael Trauner
Michael Trauner Medical University of Vienna
Heiner Wedemeyer
Heiner Wedemeyer Hannover Medical School

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in healthcare careers beyond traditional medical school, there are many flexible online degree options available. These programs can help you enter high-demand fields and may provide a more affordable and accessible pathway compared to on-campus options.

If you’re considering healthcare leadership, pursuing one of the affordable online mha programs can prepare you for administrative and management roles in hospitals, clinics, and other settings.

Nurses looking to advance their practice might explore dnp online programs cheap. These programs focus on evidence-based practice and clinical leadership, while offering the affordability and convenience of online study.

Pharmacy is another promising field. Earning a doctorate through online pharmacy programs allows you to prepare for pharmacy licensure and expand your expertise from anywhere.

Or, if you’re interested in medical data and healthcare technology, consider an education through online rhit degree programs. These programs train you to manage patient data and use health information systems, opening doors to informatics and IT roles in healthcare.

Best Scientists Citing Frank Lammert

Trending Scientists

Recently Published Articles